Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576888 · ClinicalTrials.gov registry record
Registry for Vascular Anomalies Associated With Coagulopathy
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 30
- Enrollment target
NCT00576888 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 30 participants.
The verdict
NCT00576888 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may appear red, brown or blue, often misdiagnosed as hemangiomas. The gastrointestinal tract, liver, and lungs are the most common internal organs involved. The severe thrombocytopenia (low platelets) is believed to be the result of platelet trapping within the skin and visceral vascular lesions. Severe and chronic gastrointestinal bleeding is common during infancy and early childhood. Although a relatively newly described entity, MLT was likely previously reported as hemangiomas, blue rubber bleb nevus syndrome, diffuse hemangiomatosis, Kasabach-Merritt phenomenon, and hereditary hemorrhagic telangiectasia. The term cutaneovisceral angiomatosis with thrombocytopenia is also a term used for this same disease. This study is a longitudinal cohort study of MLT to collect detailed clinical data on the distribution of disease, disease severity, and complications. This data will be used to create diagnostic criteria and an evaluation protocol for infants with this disease
Interventions
- OTHER no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-11 |
| Est. Completion | 2019-04-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576888
The ClinicalTrials.gov registry entry for NCT00576888 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which no intervention is the first listed.
NCT00576888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576888 about?
NCT00576888 is a clinical study titled "Registry for Vascular Anomalies Associated With Coagulopathy". PURPOSE The purpose of this study is to learn more about multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). MLT is a rare vascular disorder characterized by multiple congenital skin and visceral lesions, profound thrombocytopenia, and gastrointestinal bleeding. The skin lesions may ...
What is the current status of trial NCT00576888?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2007-11. Estimated completion is 2019-04-05.
What interventions are being tested in trial NCT00576888?
The interventions under investigation include: no intervention (OTHER).
Who is sponsoring clinical trial NCT00576888?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.